PACTR201812901591120
Completed
Phase 4
The comparison of efficiency of misoprostol used in different ways in postpartum hemorrhage.
Not provided0 sites400 target enrollmentNovember 29, 2018
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Not provided
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Pregnant women between the ages of 18\-40
- •2\. Having pregnancy between 37\-42 weeks
- •3\. Women on vaginal delivery
- •4\. Pregnant women with BMI \<35
- •5\. Nulliparity
Exclusion Criteria
- •1\. Women with multiple pregnancy
- •2\. Pregnant women with myoma
- •3\. Pregnant women with polyhydramnios
- •4\. Pregnant women with chorioamnionitis
- •5\. Pregnant women with placental abnormalities
- •6\. Pregnant women with bleeding diathesis
- •7\. Pregnant women with caesarean
- •8\. Pregnant women with low platelet
- •9\. Women who do not want to participate
- •10\. Pregnant women with allergic reactions to drug
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Misoprostol compared with Stachys lavandulifolia with misoprostol on the rate of abortion in the first trimesterIRCT20160524028038N7Yasouj University of Medical Sciences40
Recruiting
Phase 3
The effect of misoprostol alone and misoprostol together with vaginal estrogen in induction of laborIRCT20230611058454N1Tehran University of Medical Sciences200
Completed
Phase 3
Evaluation of the effect of misoprostol with and without letrozol in missed abortedIRCT20190730044380N1Esfahan University of Medical Sciences126
Completed
Not Applicable
Evaluation of Effectiveness of Misoprostol in Office Hysteroscopy : A Prospective Randomized Double Blind Placebo Controlled TrialCTRI/2019/04/018458All India Institute of Medical Sciences New Delhi100
Not yet recruiting
Phase 3
The effects of evening primrose oil in preparing the cervix before hysteroscopic surgeriesHysteroscopy.IRCT20230404057817N1Qazvin University of Medical Sciences120